Literature DB >> 20012495

Cognitive impairments in progression of Parkinson's disease.

D A Stepkina1, V V Zakharov, N N Yakhno.   

Abstract

A total of 88 patients with progression of Parkinson's disease (PD) were studied. Cognitive impairments (CI) in PD were in most cases progressive in nature, predominantly because of increases in the severity of dysregulatory and neurodynamic disorders, impairments to visuospatial functions, and, in some cases, deficits in nominative speech function. A high frequency of transformation of moderate cognitive impairments to dementia was demonstrated over periods of 2-5 years. Predictors of the progression of CI in PD were identified: elderly age, later onset of disease, and the severity of PD. The greatest rate of progression of CI was seen in patients with initially more severe impairments of regulatory and visuospatial functions.

Entities:  

Mesh:

Year:  2010        PMID: 20012495     DOI: 10.1007/s11055-009-9223-6

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  24 in total

1.  Risk of dementia in Parkinson's disease: a community-based, prospective study.

Authors:  D Aarsland; K Andersen; J P Larsen; A Lolk; H Nielsen; P Kragh-Sørensen
Journal:  Neurology       Date:  2001-03-27       Impact factor: 9.910

2.  Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson's disease is related to cognitive impairment.

Authors:  A Brück; T Kurki; V Kaasinen; T Vahlberg; J O Rinne
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-10       Impact factor: 10.154

3.  The influence of cerebrovascular risk factors on incident dementia in patients with Parkinson's disease.

Authors:  K Haugarvoll; D Aarsland; T Wentzel-Larsen; J P Larsen
Journal:  Acta Neurol Scand       Date:  2005-12       Impact factor: 3.209

4.  Screening for dementia by memory testing.

Authors:  E Grober; H Buschke; H Crystal; S Bang; R Dresner
Journal:  Neurology       Date:  1988-06       Impact factor: 9.910

5.  [Moderate cognitive impairment syndrome in cerebral vascular insufficiency].

Authors:  N N Iakhno; V V Zakharov; A B Lokshina
Journal:  Zh Nevrol Psikhiatr Im S S Korsakova       Date:  2005

6.  Visuospatial judgment. A clinical test.

Authors:  A L Benton; N R Varney; K D Hamsher
Journal:  Arch Neurol       Date:  1978-06

7.  Visuospatial impairment in Parkinson's disease.

Authors:  B E Levin; M M Llabre; S Reisman; W J Weiner; J Sanchez-Ramos; C Singer; M C Brown
Journal:  Neurology       Date:  1991-03       Impact factor: 9.910

8.  The FAB: a Frontal Assessment Battery at bedside.

Authors:  B Dubois; A Slachevsky; I Litvan; B Pillon
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

9.  Combined effect of age and severity on the risk of dementia in Parkinson's disease.

Authors:  Gilberto Levy; Nicole Schupf; Ming-Xin Tang; Lucien J Cote; Elan D Louis; Helen Mejia; Yaakov Stern; Karen Marder
Journal:  Ann Neurol       Date:  2002-06       Impact factor: 10.422

10.  Neuropsychological characteristics of preclinical dementia in Parkinson's disease.

Authors:  D M Jacobs; K Marder; L J Côté; M Sano; Y Stern; R Mayeux
Journal:  Neurology       Date:  1995-09       Impact factor: 9.910

View more
  8 in total

1.  Neuropsychologic assessment in collaborative Parkinson's disease research: a proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson's Disease Research at the University of Pennsylvania and the University of Washington.

Authors:  G Stennis Watson; Brenna A Cholerton; Rachel G Gross; Daniel Weintraub; Cyrus P Zabetian; John Q Trojanowski; Thomas J Montine; Andrew Siderowf; James B Leverenz
Journal:  Alzheimers Dement       Date:  2012-11-16       Impact factor: 21.566

2.  Evaluation of mild cognitive impairment subtypes in Parkinson's disease.

Authors:  Brenna A Cholerton; Cyrus P Zabetian; Jia Y Wan; Thomas J Montine; Joseph F Quinn; Ignacio F Mata; Kathryn A Chung; Amie Peterson; Alberto J Espay; Fredy J Revilla; Johnna Devoto; G Stennis Watson; Shu-Ching Hu; James B Leverenz; Karen L Edwards
Journal:  Mov Disord       Date:  2014-04-07       Impact factor: 10.338

3.  Education and risk of incident dementia during the premotor and motor phases of essential tremor (NEDICES).

Authors:  Julián Benito-León; Israel Contador; Elan D Louis; Stephanie Cosentino; Félix Bermejo-Pareja
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

4.  Progression of Cognitive Decline in Parkinson's Disease.

Authors:  Mandy Roheger; Elke Kalbe; Inga Liepelt-Scarfone
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

5.  The Influence of Body Mass Index at Diagnosis on Cognitive Decline in Parkinson's Disease.

Authors:  Han Soo Yoo; Seok Jong Chung; Phil Hyu Lee; Young H Sohn; Suk Yun Kang
Journal:  J Clin Neurol       Date:  2019-10       Impact factor: 3.077

6.  A modified version of the interlocking finger test as a bedside screening test for visuospatial deficits and dementia in Parkinson's disease.

Authors:  Nele Schmidt; Tim Strohmaier; Karsten Witt
Journal:  Brain Behav       Date:  2022-03-07       Impact factor: 3.405

7.  Clinical characteristics with an impact on ADL functions of PD patients with cognitive impairment indicative of dementia.

Authors:  Inga Liepelt-Scarfone; Monika Fruhmann Berger; Deborah Prakash; Ilona Csoti; Susanne Gräber; Walter Maetzler; Daniela Berg
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

8.  Functional correlates of optic flow motion processing in Parkinson's disease.

Authors:  Deepti Putcha; Robert S Ross; Maya L Rosen; Daniel J Norton; Alice Cronin-Golomb; David C Somers; Chantal E Stern
Journal:  Front Integr Neurosci       Date:  2014-07-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.